Carlos Augusto Rengifo Valbuena

Carlos Augusto Rengifo Valbuena

Auto-generated profile, based on publicly available information

Carlos Augusto Rengifo Valbuena


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Veterinary World
Verified
Journal Article
Open access
DTDunia Trujillo
Dunia Trujillo
MBMónica Yamile Padilla Barreto
Mónica Yamile Padilla Barreto
MSMaria del Pilar Sanchez
Maria del Pilar Sanchez
ARAnalorena Cifuentes Rincón
Analorena Cifuentes Rincón
OAOmar Leonardo Aristizabal
Omar Leonardo Aristizabal
AAAlexandre Lima de Andrade
Alexandre Lima de Andrade
This study aimed to examine the effect of PRP on re-epithelization, corneal tissue, clinical signs, and matrix metalloproteinase (MMP) expression in sheep with infectious keratoconjunctivitis.

30 March 2013
Verified
Journal Article
Open access
CCCatalina Lapuente Chala
Catalina Lapuente Chala
CVCarlos Augusto Rengifo Valbuena
Carlos Augusto Rengifo Valbuena
MRMarco Fidel Ávila Rodríguez
Marco Fidel Ávila Rodríguez
ARAngel Enrique Cespedes Rubio
Angel Enrique Cespedes Rubio
The pathophysiology of cerebral ischemia is essential for early diagnosis, neurologic recovery, the early onset of drug treatment and the prognosis of ischemic events. Experimental models of cerebral ischemia can be used to evaluate the cellular response phenomena and possible neurological protection by drugs. To characterize the cellular changes in the neuronal population and astrocytic response by the effect of Dimethyl Sulfoxide (DMSO) on a model of ischemia caused by cerebral embolism. Twenty Wistar rats were divided into four groups (n= 5). The infarct was induced with α-bovine thrombin (40 NIH/Unit.). The treated group received 90 mg (100 μL) of DMSO in saline (1:1 v/v) intraperitoneally for 5 days; ischemic controls received only NaCl (placebo) and two non-ischemic groups (simulated) received NaCl and DMSO respectively. We evaluated the neuronal (anti-NeuN) and astrocytic immune-reactivity (anti-GFAP). The results were analyzed by densitometry (NIH Image J-Fiji 1.45 software) and analysis of variance (ANOVA) with the Graph pad software (Prism 5). Cerebral embolism induced reproducible and reliable lesions in the cortex and hippocampus (CA1)., similar to those of focal models. DMSO did not reverse the loss of post-ischemia neuronal immune-reactivity, but prevented the morphological damage of neurons, and significantly reduced astrocytic hyperactivity in the somato-sensory cortex and CA1 (p <0.001). The regulatory effect of DMSO on astrocyte hyperreactivity and neuronal-astroglial cytoarchitecture , gives it potential neuroprotective properties for the treatment of thromboembolic cerebral ischemia in the acute phase.